- In December 2023, German Bionic launched the Apogee+ e-exoskeleton, designed to assist healthcare professionals with dynamic lifting aid and patient mobility support. The device reduces back strain by up to 66 pounds, enhancing safety and efficiency in medical settings. Apogee+ integrates advanced robotics to improve ergonomics, helping caregivers manage physically demanding tasks with greater ease
- In October 2023, Wandercraft launched commercial operations in the United States, following FDA approval for its self-stabilizing walking exoskeleton, Atalante X. The company established its U.S. headquarters in New York, partnering with Kessler Foundation to advance stroke rehabilitation research. Wandercraft’s expansion marks a major milestone in its global growth strategy, enhancing mobility solutions for individuals with neurological impairments
- In October 2023, SUITX by Ottobock introduced the IX BACK AIR exoskeleton, a back-support system that merges the rigidity of traditional models with the comfort of soft designs. Engineered for logistics and industrial applications, it reduces lower back strain by up to 56% while maintaining full freedom of movement. The lightweight structure enhances endurance, making it ideal for physically demanding tasks
- In June 2022, Ekso Bionics received FDA 510(k) clearance for its EksoNR robotic exoskeleton, making it the first exoskeleton approved for MS rehabilitation. This milestone expands EksoNR’s application to a broader patient population, enhancing mobility and gait training for individuals with multiple sclerosis. Previously cleared for stroke and spinal cord injury rehabilitation, EksoNR now offers advanced neurorehabilitation solutions for MS patients
